NCT00445666: Tumor-Infiltrating Lymphocytes in Treating Patients With Persistent or Recurrent B-Cell Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Multiple Myeloma After a Previous Donor Stem Cell Transplant |
|
|
| Active, not recruiting | 1 | 36 | US | graft-versus-tumor induction therapy, therapeutic tumor infiltrating lymphocytes, cytogenetic analysis, fluorescence in situ hybridization, microarray analysis, polymerase chain reaction, flow cytometry, immunoenzyme technique, immunohistochemistry staining method, immunologic technique, laboratory biomarker analysis, biopsy, conventional surgery | National Cancer Institute (NCI) | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | | | | |
NCT00810966: ABT-888 and Cyclophosphamide in Treating Patients With Solid Tumors or Lymphoma That Did Not Respond to Previous Therapy |
|
|
| Active, not recruiting | 1 | 50 | US | cyclophosphamide, veliparib, immunologic technique, laboratory biomarker analysis, liquid chromatography, mass spectrometry, pharmacological study | National Cancer Institute (NCI) | Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | | | | |
NCT00960050: Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone |
|
|
| Active, not recruiting | 1 | 173 | US | polymorphism analysis, laboratory biomarker analysis, medical chart review, assessment of therapy complications | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Leukemia, Lymphoma, Methemoglobinemia, Nonmalignant Neoplasm | 05/15 | | | |
